Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 52

Pharmacy and Therapeutics (P&T) committees exist in most hospitals and pharmacists are key members of such committees offering objective, unbiased information and advice on all aspects of drug use. Considerations of quality, cost (reimbursement), access, and procurement and interchangeability of biosimilars with innovator biologics⁸³ will be even more important to P&T committees as new emerging and even more expensive biotherapies enter the market and hospitals and insurers and governments attempt to improve clinical care within enormous budgetary constraints.